This is a StreetInsider.com Premium Only Page

Acceleron Pharma (XLRN) –

Jun 2, 2022 08:00 AM Qiming Venture Partners USA Announces $260 Million US Healthcare Fund III and Addition of New Partner, Isaac Ciechanover

Dec 7, 2021 01:12 PM Merck (MRK) to sell $8 billion in bonds for Acceleron Pharma (XLRN) deal - Bloomberg

Dec 2, 2021 09:01 AM Form 15-12B ACCELERON PHARMA INC

Nov 24, 2021 03:48 PM Form SC 13D/A ACCELERON PHARMA INC Filed by: Avoro Capital Advisors LLC

Nov 22, 2021 09:13 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Zakrzewski Joseph S

Nov 22, 2021 09:12 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Malik Kemal

Nov 22, 2021 09:11 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Hite Christopher

Nov 22, 2021 09:10 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Smith Karen L.

Nov 22, 2021 09:09 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: MCCOURT Thomas A

Nov 22, 2021 09:08 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Hamill Laura

Nov 22, 2021 09:08 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Kearney Terrence C

Nov 22, 2021 09:07 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Nader Francois

Nov 22, 2021 09:06 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Veness Adam M

Nov 22, 2021 09:05 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: KANGO SUJAY

Nov 22, 2021 09:04 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Backstrom Jay T.

Nov 22, 2021 09:03 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: Dable Habib J

Nov 22, 2021 09:03 AM Form 4 ACCELERON PHARMA INC For: Nov 19 Filed by: MCLAUGHLIN KEVIN F

Nov 22, 2021 08:52 AM Form 8-K ACCELERON PHARMA INC For: Nov 19

Nov 22, 2021 08:41 AM Form 25-NSE ACCELERON PHARMA INC Filed by: Nasdaq Stock Market LLC

Nov 22, 2021 07:02 AM Form SC 14D9/A ACCELERON PHARMA INC Filed by: ACCELERON PHARMA INC

Nov 22, 2021 07:02 AM Form SC TO-T/A ACCELERON PHARMA INC Filed by: MERCK SHARP & DOHME CORP.

Nov 22, 2021 06:45 AM Merck (MRK) Completes Acquisition of Acceleron Pharma (XLRN)

Nov 22, 2021 06:45 AM Merck Completes Acquisition of Acceleron Pharma Inc.

Nov 22, 2021 06:26 AM Merck (MRK) Completes Tender Offer to Acquire Acceleron Pharma (XLRN)

Nov 19, 2021 06:06 PM Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.

Nov 17, 2021 04:28 PM Form SC 14D9/A ACCELERON PHARMA INC Filed by: Avoro Capital Advisors LLC

Nov 17, 2021 02:26 PM Avoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate Offer

Nov 17, 2021 07:55 AM Acceleron Pharma (XLRN) Climbs 3.3% After Merck (MRK) Announces Expiration of HSR Waiting Period for Acquisition

Nov 17, 2021 07:26 AM Form SC TO-T/A ACCELERON PHARMA INC Filed by: MERCK SHARP & DOHME CORP.

Nov 17, 2021 07:01 AM Form SC 14D9/A ACCELERON PHARMA INC Filed by: ACCELERON PHARMA INC

Nov 17, 2021 06:46 AM Merck (MRK) Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Extension of Tender Offer to Acquire Acceleron Pharma (XLRN)

Nov 17, 2021 06:45 AM Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Extension of Tender Offer to Acquire Acceleron Pharma Inc.

Nov 12, 2021 04:18 PM Form 4 ACCELERON PHARMA INC For: Nov 09 Filed by: Veness Adam M

Nov 12, 2021 07:01 AM Form SC 14D9/A ACCELERON PHARMA INC Filed by: ACCELERON PHARMA INC

Nov 10, 2021 12:25 PM Form SC 13G/A ACCELERON PHARMA INC Filed by: FMR LLC

Nov 10, 2021 11:37 AM Form SC 14D9/A ACCELERON PHARMA INC Filed by: Avoro Capital Advisors LLC

Nov 10, 2021 05:56 AM Avoro Calls Merck's $180/sh Offer for Acceleron Pharma (XLRN) Inadequate; Urges Shareholders Not to Tender

Nov 9, 2021 05:31 PM Avoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate Offer

Nov 8, 2021 05:17 PM Form SC TO-T/A ACCELERON PHARMA INC Filed by: MERCK SHARP & DOHME CORP.

Nov 8, 2021 05:15 PM Form SC 14D9/A ACCELERON PHARMA INC Filed by: ACCELERON PHARMA INC

Nov 8, 2021 04:32 PM Merck (MRK) Acquisition of Acceleron Pharma Cleared by Antitrust Authorities in Germany and Austria

Nov 8, 2021 04:30 PM Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to Acquire Acceleron Pharma Inc.

Nov 4, 2021 06:56 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ROG, RRD, XLRN, ADMS; Shareholders are Encouraged to Contact the Firm

Nov 4, 2021 04:13 PM Form 10-Q ACCELERON PHARMA INC For: Sep 30

Nov 4, 2021 04:07 PM Form 8-K ACCELERON PHARMA INC For: Nov 04

Nov 4, 2021 04:01 PM Acceleron Reports Third Quarter 2021 Financial Results

Nov 2, 2021 10:02 AM Farallon Capital Opposes Terms Of Merck’s (MRK) Acceleron (XLRN) Takeover - Bloomberg

Nov 1, 2021 06:07 AM Form SC TO-T/A ACCELERON PHARMA INC Filed by: MERCK SHARP & DOHME CORP.

Nov 1, 2021 06:06 AM Form SC 14D9/A ACCELERON PHARMA INC Filed by: ACCELERON PHARMA INC

Oct 29, 2021 04:34 PM Merck Announces Withdrawal and Refiling under the Hart-Scott-Rodino Act and Extension of Tender Offer to Acquire Acceleron Pharma Inc.